Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Quinidine gluconate
Drug ID BADD_D01893
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D00642
MeSH ID C016713
PubChem ID 94328
TTD Drug ID Not Available
NDC Product Code 53489-141; 54738-901; 12065-1702; 51407-288
UNII R6875N380F
Synonyms quinidine gluconate | quinidine gluconate, (9S)-isomer | quinidine gluconate, (8alpha,9R)-isomer | Quinact | Quinaglute
Chemical Information
Molecular Formula C26H36N2O9
CAS Registry Number 6587-33-3
SMILES COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.C(C(C(C(C(C(=O)O)O)O)O)O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pneumonitis22.01.01.006--
Pruritus23.03.12.001--
Psoriasis10.02.01.036; 23.03.14.002---
Pyrexia08.05.02.003--
Rash23.03.13.001---
Seizure17.12.03.001--
Sjogren's syndrome06.08.02.011; 07.06.01.010; 10.04.04.009; 15.06.01.015---
Sleep disorder19.02.04.001---
Systemic lupus erythematosus10.04.03.004; 15.06.02.003; 23.03.02.006---
Thrombocytopenic purpura01.08.01.003; 23.06.01.007---
Tremor17.01.06.002--
Urticaria10.01.06.001; 23.04.02.001--
Uveitis06.04.03.003; 10.02.01.023--
Vasculitis10.02.02.006; 24.12.04.027--
Visual field defect06.02.07.003; 17.17.01.001---
Visual impairment06.02.10.013---
Pigmentation disorder23.05.03.001---
Skeletal muscle enzymes13.04.01.008---
Exfoliative rash23.03.07.006---
The 2th Page    First    Pre   2    Total 2 Pages